ACT is developing a portfolio of patents to protect its technology platform and specific product applications. ACT currently has 7 issued patents and 5 additional patent applications in prosecution covering the technology platform and applications:
Polypeptide Thin Films and Capsules 7,348,399 7,321,022
7,534,860
7,544,770
7,550,557Control of Film Stability and Release
of Encapsulated Agents
7,538,184 Artificial Red Blood Cells 7,411,038